Aviir Lands $8,000,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6c5e2506-d04f-4a04-ac77-412da142140a&Preview=1 -
Date
9/20/2012 -
Company Name
Aviir -
Mailing Address
2463 Faber Place Palo Alto, CA 94303 -
Company Description
Aviir is a venture-funded biotechnology company developing cutting-edge, convenient diagnostic tests enabling accurate diagnosis and prognosis of cardiovascular disease. The company’s proprietary technology draws on years of research at Stanford University, and combines the scientific founders’ deep understanding of disease marker proteins and advanced biostatistics. -
Website
http://www.aviir.com -
Transaction Type
Debt -
Transaction Amount
$8,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The funding will be used to accelerate commercialization activities and infrastructure build-out for its cardiac risk assessment portfolio of laboratory tests targeted at fostering cardiac disease prevention. -
M&A Terms
-
Venture Investor
Silicon Valley Bank
